Work

Mp78-11 Do Sarcomatoid and Rhabdoid Differentiation Have Similar Prognostic Effects for Patients With Grade 4 Renal Cell Carcinoma?

Year: 2016

Type: article

Abstract: CONCLUSIONS: Our results suggest that polymorphisms in VEGF and VEGFR2 are associated with sorafenib clinical outcomes, and polymorphisms in VEGF and ABCB1 are associated with sorafenibrelated toxicities.Larger studies are warranted to validate our findings.

Source: The Journal of Urology

DOI: 10.1016/j.juro.2016.02.1967

Authors: Onder Kara, Homayoun Zargar, Matthew Maurice, Hiury Andrade, Oktay Akca, Peter Caputo, Daniel Ramirez, Ercan Malkoc, Brian Rini, Jihad Kaouk

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2332372875

FWCI:

Cites:

Cited by:

Related to: 10